Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 18571777)

1.

Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?

Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, Moser AB, Frosch MP, Ransohoff RM.

Ann Neurol. 2008 Jun;63(6):729-42. doi: 10.1002/ana.21391.

PMID:
18571777
2.

[X-linked adrenoleukodystrophy].

Aubourg P.

Ann Endocrinol (Paris). 2007 Dec;68(6):403-11. Epub 2007 May 29. Review. French.

PMID:
17532287
3.

Cerebral inflammation in X-linked adrenoleukodystrophy.

McGuinness MC, Smith KD.

Arch Immunol Ther Exp (Warsz). 1999;47(5):281-7. Review.

PMID:
10604233
4.

Therapy of X-linked adrenoleukodystrophy.

Semmler A, Köhler W, Jung HH, Weller M, Linnebank M.

Expert Rev Neurother. 2008 Sep;8(9):1367-79. doi: 10.1586/14737175.8.9.1367. Review.

PMID:
18759549
5.

X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.

Berger J, Gärtner J.

Biochim Biophys Acta. 2006 Dec;1763(12):1721-32. Epub 2006 Jul 26. Review.

6.

X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?

Aubourg P, Dubois-Dalcq M.

Glia. 2000 Jan 15;29(2):186-90. Review. No abstract available.

PMID:
10625338
7.

Gene therapy strategies for X-linked adrenoleukodystrophy.

Cartier N.

Curr Opin Mol Ther. 2001 Aug;3(4):357-61. Review.

PMID:
11525559
8.

Microglia and inflammation: impact on developmental brain injuries.

Chew LJ, Takanohashi A, Bell M.

Ment Retard Dev Disabil Res Rev. 2006;12(2):105-12. Review.

PMID:
16807890
9.

Adrenoleukodystrophy associated with vitiligo and ulcerative colitis.

Sawaya RA, Mourad FH, Najjar S, Mikati M, Raymond GV.

Eur Neurol. 1999;42(3):169-72. Review.

PMID:
10529544
10.

[Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].

Morita M.

Yakugaku Zasshi. 2007 Jul;127(7):1059-64. Review. Japanese.

11.

The pathology of peroxisomal disorders with pathogenetic considerations.

Powers JM.

J Neuropathol Exp Neurol. 1995 Sep;54(5):710-9. Review.

PMID:
7666061
12.

Microglial clearance function in health and disease.

Napoli I, Neumann H.

Neuroscience. 2009 Feb 6;158(3):1030-8. doi: 10.1016/j.neuroscience.2008.06.046. Epub 2008 Jul 1. Review.

PMID:
18644426
13.

"Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.

Moser HW, Moser AB, Hollandsworth K, Brereton NH, Raymond GV.

J Mol Neurosci. 2007 Sep;33(1):105-13. Review.

PMID:
17901554
14.
15.

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.

Kemp S, Wanders RJ.

Mol Genet Metab. 2007 Mar;90(3):268-76. Epub 2006 Nov 7. Review.

PMID:
17092750
16.

[From gene to disease; X-linked adrenoleukodystrophy].

Engelen M, Kemp S, van Geel BM.

Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):804-8. Review. Dutch.

PMID:
18491823
17.

Leukodystrophies with late disease onset: an update.

Köhler W.

Curr Opin Neurol. 2010 Jun;23(3):234-41. doi: 10.1097/WCO.0b013e328338313a. Review.

PMID:
20216214
18.

Myelin peroxisomes - essential organelles for the maintenance of white matter in the nervous system.

Kassmann CM.

Biochimie. 2014 Mar;98:111-8. doi: 10.1016/j.biochi.2013.09.020. Epub 2013 Oct 9. Review.

19.

Brain inflammation and adult neurogenesis: the dual role of microglia.

Ekdahl CT, Kokaia Z, Lindvall O.

Neuroscience. 2009 Feb 6;158(3):1021-9. doi: 10.1016/j.neuroscience.2008.06.052. Epub 2008 Jul 3. Review.

PMID:
18662748
20.

X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.

Mahmood A, Dubey P, Moser HW, Moser A.

Pediatr Transplant. 2005 Dec;9 Suppl 7:55-62. Review.

PMID:
16305618
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk